Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Venkateswar Addala

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Science (New York, N.Y.)|May 30, 2024
Germline variants alter immune surveillanceNicola Waddell, Venkateswar Addala
Nature Reviews. Clinical Oncology|November 1, 2023
Computational immunogenomic approaches to predict response to cancer immunotherapiesVenkateswar Addala, Felicity Newell, John V Pearson, et al.
Neuro-Oncology|February 9, 2023
Efficient detection and monitoring of pediatric brain malignancies with liquid biopsy based on patient-specific somatic mutation screeningMarija Kojic, Mellissa K Maybury, Nicola Waddell, et al.
Scientific Reports|May 6, 2023
Generalising uncertainty improves accuracy and safety of deep learning analytics applied to oncologySamual MacDonald, Helena Foley, Melvyn Yap, et al.
Frontiers in Immunology|November 15, 2023
The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy - results from the AGITG DOCTOR trial and the cancer evolution biobankJames M Lonie, Sandra Brosda, Vanessa F Bonazzi, et al.
Scientific Reports|May 23, 2026
Explainable machine learning identifies features and thresholds predictive of immunotherapy responseKhoa A Tran, Venkateswar Addala, Lambros T Koufariotis, et al.
Genome Medicine|July 17, 2024
Spatial intra-tumour heterogeneity and treatment-induced genomic evolution in oesophageal adenocarcinoma: implications for prognosis and therapySandra Brosda, Lauren G Aoude, Vanessa F Bonazzi, et al.
Nature Communications|September 16, 2023
Performance of tumour microenvironment deconvolution methods in breast cancer using single-cell simulated bulk mixturesKhoa A Tran, Venkateswar Addala, Rebecca L Johnston, et al.
The Journal of Clinical Investigation|March 15, 2022
CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanismsXian-Yang Li, Indrajit Das, Ailin Lepletier, et al.
The Journal of Clinical Investigation|May 15, 2018
CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanismsXian-Yang Li, Indrajit Das, Ailin Lepletier, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Science (New York, N.Y.)|May 30, 2024
Germline variants alter immune surveillanceNicola Waddell, Venkateswar Addala
Nature Reviews. Clinical Oncology|November 1, 2023
Computational immunogenomic approaches to predict response to cancer immunotherapiesVenkateswar Addala, Felicity Newell, John V Pearson, et al.
Neuro-Oncology|February 9, 2023
Efficient detection and monitoring of pediatric brain malignancies with liquid biopsy based on patient-specific somatic mutation screeningMarija Kojic, Mellissa K Maybury, Nicola Waddell, et al.
Scientific Reports|May 6, 2023
Generalising uncertainty improves accuracy and safety of deep learning analytics applied to oncologySamual MacDonald, Helena Foley, Melvyn Yap, et al.
Frontiers in Immunology|November 15, 2023
The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy - results from the AGITG DOCTOR trial and the cancer evolution biobankJames M Lonie, Sandra Brosda, Vanessa F Bonazzi, et al.
Scientific Reports|May 23, 2026
Explainable machine learning identifies features and thresholds predictive of immunotherapy responseKhoa A Tran, Venkateswar Addala, Lambros T Koufariotis, et al.
Genome Medicine|July 17, 2024
Spatial intra-tumour heterogeneity and treatment-induced genomic evolution in oesophageal adenocarcinoma: implications for prognosis and therapySandra Brosda, Lauren G Aoude, Vanessa F Bonazzi, et al.
Nature Communications|September 16, 2023
Performance of tumour microenvironment deconvolution methods in breast cancer using single-cell simulated bulk mixturesKhoa A Tran, Venkateswar Addala, Rebecca L Johnston, et al.
The Journal of Clinical Investigation|March 15, 2022
CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanismsXian-Yang Li, Indrajit Das, Ailin Lepletier, et al.
The Journal of Clinical Investigation|May 15, 2018
CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanismsXian-Yang Li, Indrajit Das, Ailin Lepletier, et al.
Pageof 2